Keyphrases
Risk Reduction
100%
Rifaximin
100%
Covert Hepatic Encephalopathy
100%
Lactulose
75%
Hepatic Encephalopathy
62%
Acute Hepatic Encephalopathy
62%
Placebo
37%
Ammonia
37%
Hospitalization
25%
High Risk
25%
Treatment Strategy
12%
U.S. Food
12%
Antibiotics
12%
Standard of Care
12%
Randomized Placebo-controlled Trial
12%
Cognitive Change
12%
Side Effect Profile
12%
Chronic Liver Disease
12%
Coma
12%
Acute Setting
12%
Neuromuscular Abnormalities
12%
Ammonia Production
12%
Mentation
12%
Multinational Trial
12%
Colonic Bacteria
12%
Ammonia Absorption
12%
Non-absorbable Disaccharides
12%
Pharmacology, Toxicology and Pharmaceutical Science
Recurrent Disease
100%
Rifaximin
100%
Hepatic Encephalopathy
100%
Lactulose
35%
Placebo
23%
Elimination
11%
Colon Flora
5%
Side Effect
5%
Chronic Liver Disease
5%
Coma
5%
Disaccharide
5%